These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3858912

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of high doses of celiprolol in asthmatic patients.
    Doshan HD, Brown R, Applin WJ, Kapoor M, Caruso FS.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S109-11. PubMed ID: 2427837
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L, Rosenborg J, Bengtsson T, Lötvall J.
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [Abstract] [Full Text] [Related]

  • 30. Some pharmacological effects of 17(S) methyl-omega-homo-trans-delta2-PGE1 (ONO 1206).
    Adaikan PG, Karim SM.
    Prostaglandins Med; 1981 Apr; 6(4):449-58. PubMed ID: 7280119
    [Abstract] [Full Text] [Related]

  • 31. Effects of prostaglandin E1 or E2 (PGE1; PGE2) on luteal function and binding of luteinizing hormone in nonpregnant ewes.
    Weems CW, Reynolds LP, Huie JM, Hoyer GL, Behrman HR.
    Prostaglandins; 1985 Feb; 29(2):161-73. PubMed ID: 3856900
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dose-response characteristics of nebulized fenoterol in asthmatic children.
    Reilly PA, Yahav J, Mindorff C, Kazim F, Levison H.
    J Pediatr; 1983 Jul; 103(1):121-6. PubMed ID: 6864377
    [Abstract] [Full Text] [Related]

  • 37. Site of bronchodilatation with inhaled ipratropium bromide and fenoterol in normal subjects.
    Santamaria J, Guillemi S, Osborne S, Coppin C, Dahlby R, Paré PD.
    Chest; 1987 Jan; 91(1):86-90. PubMed ID: 2947783
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH, Luursema PB, Sips AP, Beumer HM, Wald FD, Cornelissen PJ.
    Respiration; 1992 Jan; 59(6):322-6. PubMed ID: 1488568
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the bronchodilating effect of oxitropium bromide and fenoterol in asthmatic children.
    Van Bever HP, Desager KN, Pauwels JH, Vermeire PA.
    Eur J Pediatr; 1994 Aug; 153(8):604-6. PubMed ID: 7957410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.